SwePub
Sök i LIBRIS databas

  Utökad sökning

id:"swepub:oai:DiVA.org:liu-199117"
 

Sökning: id:"swepub:oai:DiVA.org:liu-199117" > Psychedelic use and...

Psychedelic use and psychiatric risks

Simonsson, Otto (författare)
Karolinska Inst, Sweden; Univ Oxford, England
Goldberg, Simon B. (författare)
Univ Wisconsin, WI USA
Chambers, Richard (författare)
Monash Univ, Australia
visa fler...
Osika, Walter (författare)
Karolinska Inst, Sweden
Simonsson, Charlotta (författare)
Linköpings universitet,Medicinska fakulteten
Hendricks, Peter S. (författare)
Univ Alabama Birmingham, AL USA
visa färre...
 (creator_code:org_t)
2023
2023
Engelska.
Ingår i: Psychopharmacology. - : SPRINGER. - 0033-3158 .- 1432-2072.
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • RationaleResearch on psychedelics has recently shown promising results in the treatment of various psychiatric disorders, but relatively little remains known about the psychiatric risks associated with naturalistic use of psychedelics.ObjectiveThe objective of the current study was to investigate associations between naturalistic psychedelic use and psychiatric risks.MethodsUsing a sample representative of the US adult population with regard to sex, age, and ethnicity (N=2822), this study investigated associations between lifetime naturalistic psychedelic use, lifetime unusual visual experiences, and past 2-week psychotic symptoms.ResultsAmong respondents who reported lifetime psychedelic use (n=613), 1.3% reported having been told by a doctor or other medical professional that they had hallucinogen persisting perception disorder. In covariate-adjusted linear regression models, lifetime psychedelic use was associated with more unusual visual experiences at any point across the lifetime, but no association was observed between lifetime psychedelic use and past 2-week psychotic symptoms. There was an interaction between lifetime psychedelic use and family (but not personal) history of psychotic or bipolar disorders on past 2-week psychotic symptoms such that psychotic symptoms were highest among respondents who reported lifetime psychedelic use and a family history of psychotic or bipolar disorders and lowest among those who reported lifetime psychedelic use and no family history of psychotic or bipolar disorders.ConclusionsAlthough the results in this study should be interpreted with caution, the findings suggest that lifetime naturalistic use of psychedelics might be associated with more unusual visual experiences across the lifetime, as well as more psychotic symptoms in the past 2 weeks for individuals with a family history of psychotic or bipolar disorders and the reverse for those without such a family history. Future research should distinguish between different psychotic and bipolar disorders and should also utilize other research designs (e.g., longitudinal) and variables (e.g., polygenic risk scores) to better understand potential cause-and-effect relationships.

Ämnesord

SAMHÄLLSVETENSKAP  -- Psykologi -- Psykologi (hsv//swe)
SOCIAL SCIENCES  -- Psychology -- Psychology (hsv//eng)

Nyckelord

Psychedelics; Risks; HPPD; Psychotic; Visual

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Sök utanför SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy